© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Posted 18th February 2020

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Title21

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. From reporting to analytics, Title21 provides all the critical data at your fingertips so the right person has the right data at the right time to make the right decisions. This allows Medical Technologists, Technical and Medical Directors to focus on higher-value work, and ultimately the patient, rather than chasing down paperwork and people.

Earlier this year, Title21 was selected as the Most Outstanding Cell Therapy Software Provider for 2019 by AI’s Global Excellence Award. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Since their inception, Tile21’s Cloud and onpremise software manages critical patient, product and process data for cell and gene therapy, immunotherapy and regenerative medicine to ensure quality, compliance and traceability. Programs that implement Title21 solutions find they can scale more effectively to treat more patients and can also translate products more quickly and efficiently from bench to bedside, delivering the latest innovative therapies to patients faster and more safely.

Title21 has served FDA-regulated life science companies for many years with quality management software, so Title21’s experience has been of great service to the cell therapy segment. “Our technology is extremely flexible due to its configurability on the front end. That means that we can maintain a single code base while meeting each cancer center or cell manufacturers’ specific requirements.”

“Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day.”

“At Title21, we partner with the largest and top-rated cancer hospitals – placing the patient first. One of our greatest testimonials we hear often is that our customers want us to continue to solve more of their challenges with our technology. They ask Title21 to help provide solutions through technology to increase the quality, safety and efficiency of their programs.” Current Title21 customers have a strong influence on the technology roadmap to add value to patient therapeutic care and quality. Analytics and business intelligence are also important and play a significant role in the future of developing new cures and protocols more quickly and efficiently. Cell and gene therapy is a dynamic market and the protocols are changing rapidly as they are improved and refined.

Moving forward, the future looks bright for the team at Title21 as they continue to provide exceptional services and award-winning solutions to hospitals and biotech firms. “Our passion is to serve the many patients and their families who face life-threatening diseases by supporting the leading healthcare institutions and biotech companies with powerful tools that help them deliver innovative treatments to their patients. Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day” remarks Fischer.

Bringing the interview to a close, Lynn signs off by revealing the exciting plans which lie in the pipeline for the business, which includes their ambitions to further expand the business in the years to come, especially with the advancements in immunotherapy technology.

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
Innovative Lessons from Cleaning Businesses During COVID
Innovation
14/10/2020Innovative Lessons from Cleaning Businesses During COVID

The clean freaks were right. There is something to be said for disinfecting the office every day — and the benefits have never been clearer. As businesses reopen, most are working to reassure customers that their offices are clean and safe. To do so, they're

Read Full PostRead - Eye Icon
What Type of Compensation Can You Seek After a Car Accident?
Legal
20/06/2023What Type of Compensation Can You Seek After a Car Accident?

If you are injured in a car accident, you could claim compensation. Here are the different types of compensation that you may be able to seek.

Read Full PostRead - Eye Icon
Navigating Troubled Waters & Mastering the Art of Handling Shipping Invoice Discrepancies
News
25/04/2024Navigating Troubled Waters & Mastering the Art of Handling Shipping Invoice Discrepancies

In global commerce, handling shipping invoices can often become a perplexing issue for businesses, from small enterprises to large corporations. Missteps in this area can lead to significant financial discrepancies, strained business relationships, and delayed

Read Full PostRead - Eye Icon
The Rising Popularity of digital earning opportunities in the UK
Finance
28/02/2020The Rising Popularity of digital earning opportunities in the UK

Online Trading Platforms in the UK More and more people are taking advantage of digital earning opportunities. Powerful platforms allow you to buy and sell currencies in the biggest financial market in the world. Efficient software makes trading online possibl

Read Full PostRead - Eye Icon
UK Businesses Confess They Are Overwhelmed By Volume Of Data
Strategy
23/03/2020UK Businesses Confess They Are Overwhelmed By Volume Of Data

67% of organisations are struggling to access their data to make business decisions.

Read Full PostRead - Eye Icon
The Role Of Custom Moulding In Global Acquisition Strategies
News
26/10/2023The Role Of Custom Moulding In Global Acquisition Strategies

In today's fast-paced industrial landscape, acquisition strategies have become the lifeblood for many companies aiming to expand their global footprint.

Read Full PostRead - Eye Icon
How Wrongful Death Attorneys Help Loved Ones of Victims Seek Maximum Compensation
Legal
17/04/2023How Wrongful Death Attorneys Help Loved Ones of Victims Seek Maximum Compensation

While nothing can bring your loved one back after a wrongful death, and no amount of money can truly compensate you for your loss, receiving maximum compensation can bring your family a sense of justice, closure, and financial security.

Read Full PostRead - Eye Icon
Unlocking Efficiency: How to Enhance Energy and Cost Savings in Facilities and Warehouses
Finance
11/03/2025Unlocking Efficiency: How to Enhance Energy and Cost Savings in Facilities and Warehouses

All business with facilities and warehouses faces mounting challenges when balancing cost management with energy efficiency and sustainability goals.

Read Full PostRead - Eye Icon
Unlocking the Value of Our Ideas – What Really is Intellectual Property?
Legal
10/01/2024Unlocking the Value of Our Ideas – What Really is Intellectual Property?

In today’s dynamic, diverse and competitive business landscape, safeguarding your innovative ideas and creative assets is increasingly paramount. Many businesses' largest and most valuable assets include things which are not physical and instead are intangib



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow